These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28117883)

  • 61. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
    Al-Batran SE; Werner D
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer stem cells: the 'heartbeat' of gastric cancer.
    Xu G; Shen J; Ou Yang X; Sasahara M; Su X
    J Gastroenterol; 2013 Jul; 48(7):781-97. PubMed ID: 23184096
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
    Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
    J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An evolving paradigm of cancer stem cell hierarchies: therapeutic implications.
    Cole AJ; Fayomi AP; Anyaeche VI; Bai S; Buckanovich RJ
    Theranostics; 2020; 10(7):3083-3098. PubMed ID: 32194856
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gastric cancer stem cells: a novel therapeutic target.
    Singh SR
    Cancer Lett; 2013 Sep; 338(1):110-9. PubMed ID: 23583679
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Concise review: Emerging concepts in clinical targeting of cancer stem cells.
    Rasheed ZA; Kowalski J; Smith BD; Matsui W
    Stem Cells; 2011 Jun; 29(6):883-7. PubMed ID: 21509907
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gastric stem cells and gastric cancer stem cells.
    Han ME; Oh SO
    Anat Cell Biol; 2013 Mar; 46(1):8-18. PubMed ID: 23560232
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer stem cell targeted therapies.
    Testa U; Pelosi E; Castelli G
    Ann Ist Super Sanita; 2020; 56(3):336-350. PubMed ID: 32959800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
    Arkenau HT
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):855-66. PubMed ID: 19363621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gastric cancer: Basic aspects.
    Molina-Castro S; Pereira-Marques J; Figueiredo C; Machado JC; Varon C
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability.
    Snyder CF; Smith KC; Bantug ET; Tolbert EE; Blackford AL; Brundage MD;
    Cancer; 2017 May; 123(10):1848-1859. PubMed ID: 28085201
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents.
    Perez-Castillo Y; Sánchez-Rodríguez A; Tejera E; Cruz-Monteagudo M; Borges F; Cordeiro MNDS; Le-Thi-Thu H; Pham-The H
    PLoS One; 2018; 13(2):e0192176. PubMed ID: 29420638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correction.
    Circulation; 2015 Nov; 132(19):e234. PubMed ID: 26553722
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metastatic gastric cancer treatment: a little slow but worthy progress.
    Kanat O; O'Neil BH
    Med Oncol; 2013 Mar; 30(1):464. PubMed ID: 23335104
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rvx 208.
    Drugs R D; 2011; 11(2):207-13. PubMed ID: 21679009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gastric cancer in 2012: Defining treatment standards and novel insights into disease biology.
    Smyth EC; Cunningham D
    Nat Rev Clin Oncol; 2013 Feb; 10(2):73-4. PubMed ID: 23296114
    [No Abstract]   [Full Text] [Related]  

  • 77. Gender Dysphoria in Adults: An Overview and Primer for Psychiatrists.
    Byne W; Karasic DH; Coleman E; Eyler AE; Kidd JD; Meyer-Bahlburg HFL; Pleak RR; Pula J
    Focus (Am Psychiatr Publ); 2020 Jul; 18(3):336-350. PubMed ID: 33343244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current status and problems in development of molecular target agents for gastric cancer in Japan.
    Iwagami S; Watanabe M; Baba H
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jan; 108(1):11-8. PubMed ID: 21212590
    [No Abstract]   [Full Text] [Related]  

  • 79. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
    Hubbard JM; Grothey A
    Drugs; 2017 Jul; 77(10):1091-1103. PubMed ID: 28573435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma.
    Anandappa G; Chau I
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):529-544. PubMed ID: 28501092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.